Full-Time

Director of Pharmacy

Bidp

Deadline 8/30/26
Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center

10,001+ employees

Teaching hospital delivering patient-centered medical care

Compensation Overview

$187k - $208k/yr

Plymouth, MA, USA

In Person

On-site role at BID-Plymouth; MA pharmacy licensure required.

Category
Medical, Clinical & Veterinary (1)

Get referred to Beth Israel Deaconess Medical Center

See people who can refer or advise you

Requirements
  • Requires current pharmacy licensure in the State of Massachusetts
  • A degree in Pharmacy (advanced degree preferred) from an accredited College of Pharmacy, and a minimum of five years pharmacy management experience
  • Must possess good organizational and computer skills
  • Must possess good interpersonal and communication skills for interfacing with all levels of staff, Physicians and other contacts
Responsibilities
  • Responsible for all routine operations of the Department of Pharmacy Services. Develops programs, goals and objectives consistent with the organizations overall strategic plan.
  • Develops operational and capital budgets consistent with BID-Plymouth and BILH System, and manages operating expenses and key indicators within the budget. Develops, implements, coordinates, monitors, evaluates and integrates pharmacy services that contribute to the overall success and financial viability of pharmacy services. Uses creativity in the delivery of services and products in a highly competitive market.
  • Ensures regulatory compliance and cost savings optimization of the 340B Program.
  • Provides appropriate pharmacy representation on hospital and medical staff committees. Serves as a professional resource for Physicians, Clinical Staff and Administration. Collaborates with Medical Staff and Clinical Staff regarding pharmacy programs and services.
  • Defines and resolves issues with the medication distribution system and continually evaluates performance relative to need for improvement of processes to assure the safe and appropriate delivery of medications to all patient care areas. Plans, supports and leads Quality Improvement efforts for relevant pharmacy services.
  • Manages human resources by recruiting, selecting, hiring and orienting qualified candidates. Evaluates staff performance in an accurate, consistent, objective and timely manner. Develops core position hiring strategies and ensures opportunities for professional development. Creates a cohesive pharmacy team committed to providing distributive, clinical and service quality to all customers.
  • Develops and monitors departmental policies and procedures. Ensures compliance with state and federal regulatory agency standards.
  • Strives to improve patient safety in all aspects of performance of the above essential functions, reports/documents medication errors and attends safety in-services, when appropriate.
  • Supports and exhibits behavior consistent with the philosophy and values of BILH. Performs other related duties as assigned. Assumes accountability for special projects as assigned.
  • This position provides direct and indirect supervision to Pharmacy Supervisor, Pharmacy Technician Supervisor, Clinical Pharmacy Coordinator, Clinical Pharmacists, Pharmacy Residents, Staff Pharmacists, Pharmacy Interns, Pharmacy Supply Coordinator, Pharmacy Technicians and Secretary/Clerk.
Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center

View

Beth Israel Deaconess Medical Center (BIDMC) serves as a teaching hospital in Boston affiliated with Harvard Medical School, offering a wide range of medical services across inpatient, emergency, outpatient, and urgent care. Its care model centers on delivering high-quality medical treatment to patients, supported by patient access initiatives like OpenNotes, which lets patients view clinicians’ notes online to improve understanding and engagement in their care. The hospital also supports education and research through its affiliation with Harvard, attracting funding for studies and training programs. BIDMC differentiates itself through its patient-centered approach, active patient engagement tools, and a broad network of urgent care centers and outpatient services that extend access to healthcare. The goal is to provide comprehensive, accessible, evidence-based medical care while advancing medical education and research.

Company Size

10,001+

Company Stage

Grant

Total Funding

$5.4M

Headquarters

Boston, Massachusetts

Founded

1996

Get referred to Beth Israel Deaconess Medical Center

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Strong NIH-funded research base supports translational breakthroughs and talent attraction.
  • High outpatient volume and urgent care footprint drive referral and ambulatory growth.
  • Pathology leadership additions deepen Dana-Farber collaboration and hematologic oncology specialization.

What critics are saying

  • Elite Boston talent competition pressures retention, promotion, and research continuity.
  • NIH funding dependence exposes research revenue, prestige, and recruiting to grant volatility.
  • Commercial adoption of ADAMTS13 therapies can outpace BIDMC's discovery-driven narrative.

What makes Beth Israel Deaconess Medical Center unique

  • Harvard Medical School teaching hospital with deep research and education integration.
  • Beth Israel Lahey Health scale expands access across academic, community, and specialty care.
  • OpenNotes-style transparency strengthens patient engagement and care coordination.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

Tuition Reimbursement

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Florida A&M University
Jun 18th, 2026
FAMU professor named Fulbright U.S. Scholar, will research AI in psychology at Czech University.

FAMU professor named Fulbright U.S. Scholar, will research AI in psychology at Czech University. June 18, 2026 By Heather Johnson TALLAHASSEE, Fla. - Florida A&M University (FAMU) psychology professor Huijun Li, Ph.D., has been named a 2026-2027 Fulbright U.S. Scholar, one of the most competitive and prestigious academic exchange designations in the United States. The Fulbright U.S. Scholar Program is administered by the U.S. Department of State's Bureau of Educational and Cultural Affairs. The program sends American faculty, researchers and professionals abroad each year to lecture and conduct research at host institutions in more than 130 countries. Li received the award in April, and she will travel to the Czech Republic in January 2027 for a seven-month appointment at Palacky University (UP), where she will conduct research and teach on the integration of artificial intelligence (AI) into psychological education and research. "I was very excited, and it's unbelievable because I know it is very competitive," Li said. "I'm looking forward to the cultural exchange, and I will be happy to share what I will learn with my students and colleagues." The project will center on an AI-powered app that includes mindfulness exercises and activities designed to help users recognize and constructively manage stress. Li said the timing aligns with the Czech Republic's national strategic plan, which calls for using AI to improve quality of life through 2030. "I really caught that point that this country is prioritizing AI in improving people's lives," she said. Li is a professor for FAMU's College of Social Sciences, Arts and Humanities (CSSAH) Department of Psychology and assistant director of the University's Center for Ethnic Psychological Research and Application. Her research focuses on youth mental health disparities within underserved populations, including mobile health technology, beliefs about the causes of mental illness, stigma, and barriers to care Since joining FAMU, she has secured more than $7 million in federal and foundation research grants and has authored or co-authored more than 50 peer-reviewed publications, books, book chapters and translated works. Li said the breadth of her output reflects the strength of her collaborative networks. "It's not only me doing all of these things," she said. "There are different research teams who work together, and we have become very productive." Her scholarship includes editing the 2019 volume "Handbook of Attenuated Psychosis Syndromes Across Cultures: International Perspectives on Early Identification and Intervention," published by Springer. The book draws on research from clinical programs across multiple countries to advance early identification and intervention for youth at risk for psychotic disorders. Her most recent funding award, a $399,971 grant from the National Science Foundation (NSF), launched in September 2025 and supports Boldly RISE, a student retention and wellness initiative at FAMU. The three-year project examines how social connectedness and behavioral health shape academic outcomes for first-year college students and is designed to inform retention strategies at institutions nationwide. Before joining FAMU, Li served as director of multicultural research at Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School. Li earned a doctorate in school psychology from the University of Arizona in 2003. She also holds an undergraduate degree in English and a graduate degree in applied linguistics, both earned in China. She served on the editorial boards of the Asian Journal of Psychiatry and Psychology in the Schools. Li was named FAMU's Emerging Researcher of the Year in 2014 and Distinguished Researcher in the non-STEM category in 2024.

Inshorts
Jan 10th, 2025
BIDMC introduces POCUS training for medical faculty in Pune

BIDMC introduces POCUS training for medical faculty in Pune

Hebrew SeniorLife
Dec 18th, 2024
Sarah Berry, MD, MPH, Named Gerontology Division Chief at Beth Israel Deaconess Medical Center

Sarah D. Berry, MD, MPH, has accepted the position of chief of the Division of Gerontology at Beth Israel Deaconess Medical Center, succeeding Lewis Lipsitz, MD, beginning in February 2025.

Beth Israel Deaconess Medical Center
Nov 1st, 2024
BIDMC Awarded $9.1 Million To Advance Assessment and Treatment of Brain Disorders in Women

BIDMC will receive $9.1 million to assess brain disorders in women through a new, non-invasive MRI imaging biomarker.